EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy

Panoraia Baka iD, Livia Steenken, Fabiola Escolano-Lozano, Falk Steffen, Aikaterini Papagianni, Claudia Sommer, Esther Pogatzki-Zahn, Silke Hirsch, Maria Protopapa, Stefan Bittner, Frank Birklein

European Journal of Neurology · 2024

DOI: 10.1111/ene.16192 ↗

At a glance

Journal article in European Journal of Neurology, 2024. Written by Panoraia Baka and 10 co-authors. Institution: Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Major MEDLINE topics: Small Fiber Neuropathy, Peripheral Nervous System Diseases. Cited 13 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Diagnosing small fiber neuropathies can be challenging. To address this issue, whether serum neurofilament light chain (sNfL) could serve as a potential biomarker of damage to epidermal Aδ‐ and C‐fibers was tested.

Methods

Serum NfL levels were assessed in 30 patients diagnosed with small fiber neuropathy and were compared to a control group of 19 healthy individuals. Electrophysiological studies, quantitative sensory testing and quantification of intraepidermal nerve fiber density after skin biopsy were performed in both the proximal and distal leg.

Results

Serum NfL levels were not increased in patients with small fiber neuropathy compared to healthy controls (9.1 ± 3.9 and 9.4 ± 3.8, p = 0.83) and did not correlate with intraepidermal nerve fiber density at the lateral calf or lateral thigh or with other parameters of small fiber impairment.

Conclusion

Serum NfL levels cannot serve as a biomarker for small fiber damage.

Subjects

MeSH terms (MEDLINE)

Small Fiber NeuropathyPeripheral Nervous System DiseasesHumansIntermediate FilamentsNerve FibersEpidermisSkinBiopsy

Author keywords

axonal degenerationbiomarkerintraepidermal nerve fiber densityserum neurofilament light chainsmall fiber neuropathy

Authors and institutions

  • Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Department of Neurology, University Hospital of Würzburg, Würzburg, Germany.
  • Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.

ORCID profiles: Panoraia Baka

Funding

  • Deutsche Forschungsgemeinschaft

Cite

APA

Baka, P., Steenken, L., Escolano-Lozano, F., Steffen, F., Papagianni, A., Sommer, C., Pogatzki-Zahn, E., Hirsch, S., Protopapa, M., Bittner, S., & Birklein, F. (2024). Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16192

Vancouver

Baka P, Steenken L, Escolano-Lozano F, Steffen F, Papagianni A, Sommer C, et al. Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16192

BibTeX
@article{Baka2024,
  author = {Baka, Panoraia and Steenken, Livia and Escolano-Lozano, Fabiola and Steffen, Falk and Papagianni, Aikaterini and Sommer, Claudia and Pogatzki-Zahn, Esther and Hirsch, Silke and Protopapa, Maria and Bittner, Stefan and Birklein, Frank},
  title = {Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16192}
}
Start for free →